Literature DB >> 29356898

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.

Jessica Cusato1, Lucio Boglione2, Amedeo De Nicolò2, Fabio Favata2, Alessandra Ariaudo2, Simone Mornese Pinna2, Federica Guido2, Valeria Avataneo2, Marco Cantù3, Chiara Carcieri2, Giuseppe Cariti2, Giovanni Di Perri2, Antonio D'Avolio2.   

Abstract

PURPOSE: Since HCV infection may lead to hepatocellular carcinoma (HCC) and vitamin D (deficiency) is related to cancer, we investigated if SNPs in genes involved in vitamin D pathway could predict HCV-related HCC presence in patients treated with new anti-HCV drugs.
METHODS: Patients with chronic hepatitis C and treated with direct-acting antivirals were enrolled. SNPs in VDR, CYP27B1, CYP24A1 and GC genes were assessed through real-time PCR. 258 patients were analyzed.
RESULTS: HCC was present in six patients, all taking sofosbuvir, all males and five/six had cirrhosis. HCV-RNA log levels at baseline were statistically different between patients with and without HCC. VDR FokI T > C SNP resulted associated with HCC: all the CC patients were free from HCC. An association between HCC presence and undetectable HCV-RNA at 1 month of therapy was suggested; cirrhosis was related to HCC. HCC risk factors were age, ribavirin administration, IL28Brs12979860CC and previous treatments; VDR FokICC, sex and insulin resistance were protective factors.
CONCLUSIONS: These data highlighted vitamin D pathway gene SNPs and HCC relationship in the Italian population; further studies are required.

Entities:  

Keywords:  Hepatocellular carcinoma; Pharmacogenetics; SNP; Sofosbuvir; VDR; Viral hepatitis; Vitamin D

Mesh:

Substances:

Year:  2018        PMID: 29356898     DOI: 10.1007/s00280-018-3520-0

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  5 in total

1.  Lack of association between CYP27B1 gene polymorphism and type 2 diabetes mellitus in Iranian patients.

Authors:  Saiedeh Erfanian; Abazar Roustazadeh
Journal:  J Diabetes Metab Disord       Date:  2022-03-14

2.  Influence of vitamin D on cancer risk and treatment: Why the variability?

Authors:  M Rita I Young; Ying Xiong
Journal:  Trends Cancer Res       Date:  2018

3.  CYP27B1 Gene Polymorphism rs10877012 in Patients Diagnosed with Colorectal Cancer.

Authors:  Maria Latacz; Jadwiga Snarska; Elżbieta Kostyra; Konrad Wroński; Ewa Fiedorowicz; Huub Savelkoul; Beata Jarmołowska; Janusz Płomiński; Roman Grzybowski; Anna Cieślińska
Journal:  Nutrients       Date:  2020-04-03       Impact factor: 5.717

Review 4.  Single Nucleotide Polymorphisms in 25-Hydroxyvitamin D3 1-Alpha-Hydroxylase (CYP27B1) Gene: The Risk of Malignant Tumors and Other Chronic Diseases.

Authors:  Maria Latacz; Jadwiga Snarska; Elżbieta Kostyra; Ewa Fiedorowicz; Huub Fj Savelkoul; Roman Grzybowski; Anna Cieślińska
Journal:  Nutrients       Date:  2020-03-18       Impact factor: 5.717

5.  Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy.

Authors:  Jessica Cusato; Lucio Boglione; Amedeo De Nicolò; Gian Paolo Caviglia; Simone Mornese Pinna; Alessia Ciancio; Giulia Troshina; Antonina Smedile; Miriam Antonucci; Valeria Avataneo; Alice Palermiti; Jacopo Mula; Alessandra Manca; Giuseppe Cariti; Marco Cantù; Giorgio Maria Saracco; Giovanni Di Perri; Antonio D'Avolio
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.